USPTO serial 90772703
BRAINBOX SOLUTIONS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 28, 2022
- Examiner
- MURRAY, DAVID T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BRAINBOX SOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan K. Bowen
Megan K. Bowen Edell, Shapiro & Finnan LLC9801 WASHINGTONIAN BOULEVARD, SUITE 750GAITHERSBURG, MD 20878UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Clinical and in vitro diagnostic reagents for medical use; Clinical and in vitro diagnostic reagents for medical use, namely, immunoassay test kits, consisting primarily of in vitro reagents for the diagnosis, prognosis, and monitoring of conditions of physiological significance; Clinical and in vitro diagnostic reagents for medical diagnostic assay kits composed primarily of clinical and in vitro medical diagnostic reagents and also composed of laboratory equipment being microarrays for testing and analysis of body fluids, for medical diagnosis; Medical diagnostic assay test kits composed primarily of clinical and in vitro medical diagnostic reagents and also composed of laboratory equipment being microarrays for testing and analysis of body fluids | ACTIVE | Dec 15, 2020 |
| 010 | Medical testing devices for measuring disease markers, in the fields of immunoassays, and molecular diagnostics, including the use of an assay test panel, composed of one or more brain-enriched biomarkers, and for measuring blood flow and imaging for the purposes of identifying, testing for, detecting, monitoring, and reporting on brain and head trauma and injury | ACTIVE | Dec 15, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BRAINBOX SOLUTIONS, INC.
- Other trademarks owned by BRAINBOX SOLUTIONS, INC.
- Other trademarks owned by BRAINBOX SOLUTIONS, INC.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named BRAINBOX SOLUTIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 28, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 28, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 12, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 12, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 23, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 9, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 9, 2022 | ALIE | ASSIGNED TO LIE | — |
| Mar 4, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 4, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 4, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 3, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 26, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 26, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 2, 2021 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 1, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2021 | NWAP | NEW APPLICATION ENTERED | — |